Literature DB >> 3285126

Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

P J Neuvonen1, K T Olkkola.   

Abstract

Activated charcoal has an ability to adsorb a wide variety of substances. This property can be applied to prevent the gastrointestinal absorption of various drugs and toxins and to increase their elimination, even after systemic absorption. Single doses of oral activated charcoal effectively prevent the gastrointestinal absorption of most drugs and toxins present in the stomach at the time of charcoal administration. Known exceptions are alcohols, cyanide, and metals such as iron and lithium. In general, activated charcoal is more effective than gastric emptying. However, if the amount of drug or poison ingested is very large or if its affinity to charcoal is poor, the adsorption capacity of activated charcoal can be saturated. In such cases properly performed gastric emptying is likely to be more effective than charcoal alone. Repeated dosing with oral activated charcoal enhances the elimination of many toxicologically significant agents, e.g. aspirin, carbamazepine, dapsone, dextropropoxyphene, cardiac glycosides, meprobamate, phenobarbitone, phenytoin and theophylline. It also accelerates the elimination of many industrial and environmental intoxicants. In acute intoxications 50 to 100g activated charcoal should be administered to adult patients (to children, about 1 g/kg) as soon as possible. The exceptions are patients poisoned with caustic alkalis or acids which will immediately cause local tissue damages. To avoid delays in charcoal administration, activated charcoal should be a part of first-aid kits both at home and at work. The 'blind' administration of charcoal neither prevents later gastric emptying nor does it cause serious adverse effects provided that pulmonary aspiration in obtunded patients is prevented. In severe acute poisonings oral activated charcoal should be administered repeatedly, e.g. 20 to 50g at intervals of 4 to 6 hours, until recovery or until plasma drug concentrations have fallen to non-toxic levels. In addition to increasing the elimination of many drugs and toxins even after their systemic absorption, repeated doses of charcoal also reduce the risk of desorbing from the charcoal-toxin complex as the complex passes through the gastrointestinal tract. Charcoal will not increase the elimination of all substances taken. However, as the drug history in acute intoxications is often unreliable, repeated doses of oral activated charcoal in severe intoxications seem to be justified unless the toxicological laboratory has identified the causative agent as not being prone to adsorption by charcoal. The role of repeated doses of oral activated charcoal in chronic intoxication has not been clearly defined.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285126     DOI: 10.1007/bf03259930

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  140 in total

1.  Experimental studies on the pharmacology of activated charcoal; the effect of pH on the adsorption by charcoal from aqueous solutions.

Authors:  A H ANDERSEN
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1947

Review 2.  Activated charcoal. A neglected antidote.

Authors:  A L Picchioni
Journal:  Pediatr Clin North Am       Date:  1970-08       Impact factor: 3.278

3.  Relationship between effect of activated charcoal on drug absorption in man and its drug adsorption characteristics in vitro.

Authors:  T Tsuchiya; G Levy
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

4.  Adsorption of propoxyphene hydrochloride by activated charcoal.

Authors:  S M Chernish; R L Wolen; B E Rodda
Journal:  Clin Toxicol       Date:  1972       Impact factor: 4.467

5.  Adsorption of drugs and poisons by activated charcoal.

Authors:  W J Decker; H F Combs; D G Corby
Journal:  Toxicol Appl Pharmacol       Date:  1968-11       Impact factor: 4.219

6.  Activated charcoal vs. "universal antidote" as an antidote for poisons.

Authors:  A L Picchioni; L Chin; H L Verhulst; B Dieterle
Journal:  Toxicol Appl Pharmacol       Date:  1966-05       Impact factor: 4.219

7.  Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH.

Authors:  S Kärkkäinen; P J Neuvonen
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1986-06

8.  Acute dapsone intoxication: clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination.

Authors:  P J Neuvonen; E Elonen; E J Haapanen
Journal:  Acta Med Scand       Date:  1983

9.  Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Activated charcoal in oral ethanol absorption: lack of effect in humans.

Authors:  A Minocha; D A Herold; J T Barth; D A Gideon; D A Spyker
Journal:  J Toxicol Clin Toxicol       Date:  1986
View more
  24 in total

Review 1.  Activated charcoal in the treatment of drug overdose. An update.

Authors:  W Palatnick; M Tenenbein
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

Review 2.  Pharmacokinetics of drugs in overdose.

Authors:  Y J Sue; M Shannon
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

3.  Effect of activated charcoal on frusemide induced diuresis: a human class experiment for medical students.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

4.  The effect of cholestyramine and activated charcoal on glipizide absorption.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

5.  The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach.

Authors:  Lena E Friberg; Geoffrey K Isbister; L Peter Hackett; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

6.  Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.

Authors:  H Stass; D Kubitza; J-G Möller; H Delesen
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

Review 7.  Acute poisoning: understanding 90% of cases in a nutshell.

Authors:  S L Greene; P I Dargan; A L Jones
Journal:  Postgrad Med J       Date:  2005-04       Impact factor: 2.401

8.  Management principles for the overdosed patient.

Authors:  I Vicas
Journal:  Can Fam Physician       Date:  1988-10       Impact factor: 3.275

Review 9.  A reassessment of the treatment of salicylate poisoning.

Authors:  L Notarianni
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

10.  A ready-to-use activated charcoal mixture. Adsorption studies in vitro and in dogs: its influence on the intestinal secretion of theophylline in a rat model.

Authors:  C M Rademaker; A van Dijk; M H de Vries; F Kadir; J H Glerum
Journal:  Pharm Weekbl Sci       Date:  1989-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.